United Kingdom: Healthcare

A mother shares the heartbreaking story of her 22-year-old daughter's death from ketamine addiction, revealing how recreational drug use spiraled into a debilitating condition called ketamine bladder that caused chronic pain and ultimately led to fatal complications. The case exposes critical gaps in healthcare support for ketamine addiction and raises urgent questions about education, treatment pathways, and the accessibility of this Class B substance.

The term 'ordinarily resident' appears throughout UK immigration and nationality law, yet has never been formally defined in statute. Understanding how ordinary residence is assessed through case law, particularly the landmark Shah test, is crucial for British citizenship applications, settlement routes, and NHS access eligibility.

The phrase "clinically proven" is one of the most powerful claims in a beauty marketer's ‘Arsenal’*. It sounds scientific, authoritative, and reassuring. But in a ruling published in April 2026,...

Regulatory frameworks for AI-driven healthcare are rapidly evolving across the EU and UK, with new pilots, data governance rules, and institutional reforms taking shape. How are regulators balancing innovation with patient safety as they move from policy ambition to practical implementation of AI in medical devices, health data access, and clinical decision-making?

This report examines critical commercial, legal and regulatory challenges facing life sciences and healthcare companies globally, from shareholder activism and AI-powered drug...

Welcome to the latest installment of Arnold & Porter’s Virtual and Digital Health Digest. This digest covers key virtual and digital health regulatory and public policy developments...

On 16 February 2026, the UK's Medicines and Healthcare products Regulatory Agency ("MHRA") opened a public consultation on proposals...

January 2026 saw significant activity as UK and EU authorities advanced major initiatives affecting the use of AI, digital technologies, data governance, and cybersecurity in healthcare and life sciences.

This article analyses the recent Court of Appeal decision in Salts Healthcare Ltd v Pelican Healthcare Ltd [2026] EWCA Civ 93, which addresses several important issues in patent law.